ChloroquineV1, Pmc, Corpus, bibRecord, 000739

Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation

Identifieur interne : 000739 ( Pmc/Corpus ); précédent : 000738; suivant : 000740

Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation

Auteurs : Myoung Seok Jeong ; Ji Hoon Jung ; Hyemin Lee ; Chang Geun Kim ; Sung-Hoon Kim

Source :

OncoTargets and therapy [ 1178-6930 ] ; 2019.

RBID : PMC:6815788

Abstract

Background

To develop a potent anticancer agent similar to oleanolate, the underlying mechanisms of its derivative, methyloleanolate, in the apoptosis and autophagy of A549 and H1299 cells were elucidated.

Purpose

The aim of the present study was to investigate the effect of methyloleanolate in inducing apoptotic and autophagic cell death in cancer cells.

Materials and methods

Flow cytometric analysis with Annexin V/PI staining, Western blot analysis, and immunofluorescence analysis were conducted in A549 and H1299 cells.

Results

Methyloleanolate increased the fraction of Annexin V/PI apoptotic cells and activated caspase-8, caspase-3, and death receptor 5 (DR5) more than oleanolate in A549 and H1299 cells pretreated with pancaspase inhibitor z-VAD-fmk and DR5 depletion. Also, methyloleanolate induced autophagic features of microtubule-associated protein light chain 3 3BII (LC3BII) conversion and puncta in A549 and H1299 cells, along with autophagosomes and vacuoles. Methyloleanolate blocked autophagy flux for impaired autophagy and chloroquine (CQ)-enhanced microtubule-associated protein LC3BII accumulation and cytotoxicity in A549 and H1299 cells, although 3-methyladenine (3-MA) did not. Interestingly, LC3BII accumulation was detected only in methyloleanolate-treated autophagy-related gene 5 (ATG5)^+/+ mouse embryonic fibroblast (MEF) cells but not in ATG5^−/- MEF cells. Methyloleanolate reduced p-mTOR but activated p-c-Jun N-terminal kinases and reactive oxygen species production in A549 and H1299 cells. Conversely, n-acetyl-l-cysteine and SP600125 blocked apoptotic and autophagic cascades caused by methyloleanolate in A549 and H1299 cells.

Conclusion

Overall, the findings suggest that methyloleanolate induces apoptotic and autophagic cell death in non–small cell lung cancers via reactive oxygen species generation and c-Jun N-terminal kinase phosphorylation.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815788

DOI: 10.2147/OTT.S211904
PubMed: 31695422
PubMed Central: 6815788

Links to Exploration step

PMC:6815788

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation</title>
<author><name sortKey="Jeong, Myoung Seok" sort="Jeong, Myoung Seok" uniqKey="Jeong M" first="Myoung Seok" last="Jeong">Myoung Seok Jeong</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Jung, Ji Hoon" sort="Jung, Ji Hoon" uniqKey="Jung J" first="Ji Hoon" last="Jung">Ji Hoon Jung</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lee, Hyemin" sort="Lee, Hyemin" uniqKey="Lee H" first="Hyemin" last="Lee">Hyemin Lee</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kim, Chang Geun" sort="Kim, Chang Geun" uniqKey="Kim C" first="Chang Geun" last="Kim">Chang Geun Kim</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kim, Sung Hoon" sort="Kim, Sung Hoon" uniqKey="Kim S" first="Sung-Hoon" last="Kim">Sung-Hoon Kim</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">31695422</idno>
<idno type="pmc">6815788</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815788</idno>
<idno type="RBID">PMC:6815788</idno>
<idno type="doi">10.2147/OTT.S211904</idno>
<date when="2019">2019</date>
<idno type="wicri:Area/Pmc/Corpus">000739</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000739</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation</title>
<author><name sortKey="Jeong, Myoung Seok" sort="Jeong, Myoung Seok" uniqKey="Jeong M" first="Myoung Seok" last="Jeong">Myoung Seok Jeong</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Jung, Ji Hoon" sort="Jung, Ji Hoon" uniqKey="Jung J" first="Ji Hoon" last="Jung">Ji Hoon Jung</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lee, Hyemin" sort="Lee, Hyemin" uniqKey="Lee H" first="Hyemin" last="Lee">Hyemin Lee</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kim, Chang Geun" sort="Kim, Chang Geun" uniqKey="Kim C" first="Chang Geun" last="Kim">Chang Geun Kim</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Kim, Sung Hoon" sort="Kim, Sung Hoon" uniqKey="Kim S" first="Sung-Hoon" last="Kim">Sung-Hoon Kim</name>
<affiliation><nlm:aff id="AFF0001"><institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">OncoTargets and therapy</title>
<idno type="eISSN">1178-6930</idno>
<imprint><date when="2019">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S2001"><title>Background</title>
<p>To develop a potent anticancer agent similar to oleanolate, the underlying mechanisms of its derivative, methyloleanolate, in the apoptosis and autophagy of A549 and H1299 cells were elucidated.</p>
</sec>
<sec id="S2002"><title>Purpose</title>
<p>The aim of the present study was to investigate the effect of methyloleanolate in inducing apoptotic and autophagic cell death in cancer cells.</p>
</sec>
<sec id="S2003"><title>Materials and methods</title>
<p>Flow cytometric analysis with Annexin V/PI staining, Western blot analysis, and immunofluorescence analysis were conducted in A549 and H1299 cells.</p>
</sec>
<sec id="S2004"><title>Results</title>
<p>Methyloleanolate increased the fraction of Annexin V/PI apoptotic cells and activated caspase-8, caspase-3, and death receptor 5 (DR5) more than oleanolate in A549 and H1299 cells pretreated with pancaspase inhibitor z-VAD-fmk and DR5 depletion. Also, methyloleanolate induced autophagic features of microtubule-associated protein light chain 3 3BII (LC3BII) conversion and puncta in A549 and H1299 cells, along with autophagosomes and vacuoles. Methyloleanolate blocked autophagy flux for impaired autophagy and chloroquine (CQ)-enhanced microtubule-associated protein LC3BII accumulation and cytotoxicity in A549 and H1299 cells, although 3-methyladenine (3-MA) did not. Interestingly, LC3BII accumulation was detected only in methyloleanolate-treated autophagy-related gene 5 (<italic>ATG5</italic>
)<sup>+/+</sup>
 mouse embryonic fibroblast (MEF) cells but not in <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells. Methyloleanolate reduced p-mTOR but activated p-c-Jun N-terminal kinases and reactive oxygen species production in A549 and H1299 cells. Conversely, <sc>n</sc>
-acetyl-<sc>l</sc>
-cysteine and SP600125 blocked apoptotic and autophagic cascades caused by methyloleanolate in A549 and H1299 cells.</p>
</sec>
<sec id="S2005"><title>Conclusion</title>
<p>Overall, the findings suggest that methyloleanolate induces apoptotic and autophagic cell death in non–small cell lung cancers via reactive oxygen species generation and c-Jun N-terminal kinase phosphorylation.</p>
</sec>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Onco Targets Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">Onco Targets Ther</journal-id>
<journal-id journal-id-type="publisher-id">OTT</journal-id>
<journal-id journal-id-type="pmc">ott</journal-id>
<journal-title-group><journal-title>OncoTargets and therapy</journal-title>
</journal-title-group>
<issn pub-type="epub">1178-6930</issn>
<publisher><publisher-name>Dove</publisher-name>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">31695422</article-id>
<article-id pub-id-type="pmc">6815788</article-id>
<article-id pub-id-type="publisher-id">211904</article-id>
<article-id pub-id-type="doi">10.2147/OTT.S211904</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group><article-title>Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation</article-title>
<alt-title alt-title-type="running-authors">Jeong et al</alt-title>
<alt-title alt-title-type="running-title">Jeong et al</alt-title>
</title-group>
<contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Jeong</surname>
<given-names>Myoung Seok</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
<xref ref-type="author-notes" rid="FT0001"></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5644-5960</contrib-id>
<name><surname>Jung</surname>
<given-names>Ji Hoon</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
<xref ref-type="author-notes" rid="FT0001"></xref>
</contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3910-5611</contrib-id>
<name><surname>Lee</surname>
<given-names>Hyemin</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Kim</surname>
<given-names>Chang Geun</given-names>
</name>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2423-1973</contrib-id>
<name><surname>Kim</surname>
<given-names>Sung-Hoon</given-names>
</name>
<xref ref-type="corresp" rid="AN0001"></xref>
<xref ref-type="aff" rid="AFF0001">1</xref>
</contrib>
<aff id="AFF0001"><label>1</label>
<institution>College of Korean Medicine, Kyung Hee University</institution>
,<addr-line>Dongdaemun-Gu</addr-line>
,<addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
,<country>Republic of Korea</country>
</aff>
</contrib-group>
<author-notes><corresp id="AN0001">Correspondence: Sung-Hoon Kim <institution>College of Korean Medicine, Kyung Hee University</institution>
, <addr-line>26, Kyungheedae-ro</addr-line>
, <addr-line>Dongdaemun-gu</addr-line>
, <addr-line>Seoul</addr-line>
<addr-line>02447</addr-line>
, <country>Republic of Korea</country>
<phone>Tel +82-2-961-9233</phone>
<fax>Fax +82-2-961-9598</fax>
 Email sungkim7@khu.ac.kr</corresp>
<fn id="FT0001"><label>*</label>
<p>These authors contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub"><day>23</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection"><year>2019</year>
</pub-date>
<volume>12</volume>
<fpage>8621</fpage>
<lpage>8635</lpage>
<history><date date-type="received"><day>11</day>
<month>4</month>
<year>2019</year>
</date>
<date date-type="accepted"><day>01</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions><copyright-statement>© 2019 Jeong et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Jeong et al.</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>
 and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>
). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>
).</license-p>
</license>
</permissions>
<abstract><sec id="S2001"><title>Background</title>
<p>To develop a potent anticancer agent similar to oleanolate, the underlying mechanisms of its derivative, methyloleanolate, in the apoptosis and autophagy of A549 and H1299 cells were elucidated.</p>
</sec>
<sec id="S2002"><title>Purpose</title>
<p>The aim of the present study was to investigate the effect of methyloleanolate in inducing apoptotic and autophagic cell death in cancer cells.</p>
</sec>
<sec id="S2003"><title>Materials and methods</title>
<p>Flow cytometric analysis with Annexin V/PI staining, Western blot analysis, and immunofluorescence analysis were conducted in A549 and H1299 cells.</p>
</sec>
<sec id="S2004"><title>Results</title>
<p>Methyloleanolate increased the fraction of Annexin V/PI apoptotic cells and activated caspase-8, caspase-3, and death receptor 5 (DR5) more than oleanolate in A549 and H1299 cells pretreated with pancaspase inhibitor z-VAD-fmk and DR5 depletion. Also, methyloleanolate induced autophagic features of microtubule-associated protein light chain 3 3BII (LC3BII) conversion and puncta in A549 and H1299 cells, along with autophagosomes and vacuoles. Methyloleanolate blocked autophagy flux for impaired autophagy and chloroquine (CQ)-enhanced microtubule-associated protein LC3BII accumulation and cytotoxicity in A549 and H1299 cells, although 3-methyladenine (3-MA) did not. Interestingly, LC3BII accumulation was detected only in methyloleanolate-treated autophagy-related gene 5 (<italic>ATG5</italic>
)<sup>+/+</sup>
 mouse embryonic fibroblast (MEF) cells but not in <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells. Methyloleanolate reduced p-mTOR but activated p-c-Jun N-terminal kinases and reactive oxygen species production in A549 and H1299 cells. Conversely, <sc>n</sc>
-acetyl-<sc>l</sc>
-cysteine and SP600125 blocked apoptotic and autophagic cascades caused by methyloleanolate in A549 and H1299 cells.</p>
</sec>
<sec id="S2005"><title>Conclusion</title>
<p>Overall, the findings suggest that methyloleanolate induces apoptotic and autophagic cell death in non–small cell lung cancers via reactive oxygen species generation and c-Jun N-terminal kinase phosphorylation.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author"><title>Keywords</title>
<kwd>methyloleanolate</kwd>
<kwd>apoptosis</kwd>
<kwd>autophagy</kwd>
<kwd>JNK</kwd>
<kwd>ROS</kwd>
</kwd-group>
<counts><fig-count count="7"></fig-count>
<ref-count count="50"></ref-count>
<page-count count="15"></page-count>
</counts>
</article-meta>
</front>
<body><sec sec-type="intro" id="S0001"><title>Introduction</title>
<p>Lung cancer causes 1.6 million deaths annually worldwide.<xref rid="CIT0001" ref-type="bibr">1</xref>
 Eighty percent of lung cancers are non–small cell lung cancers (NSCLCs), which have a poor prognosis.<xref rid="CIT0002" ref-type="bibr">2</xref>
 In particular, NSCLC is known to develop drug resistance by means of epidermal growth factor receptor mutation and anaplastic lymphoma kinase translocation.<xref rid="CIT0003" ref-type="bibr">3</xref>
 Epidermal growth factor receptor inhibitor gefitinib<xref rid="CIT0004" ref-type="bibr">4</xref>
,<xref rid="CIT0005" ref-type="bibr">5</xref>
 and anaplastic lymphoma kinase inhibitor crizotinib<xref rid="CIT0006" ref-type="bibr">6</xref>
 have been applied to combat drug resistance. Recently, natural compounds such as cucurbitacin<xref rid="CIT0007" ref-type="bibr">7</xref>
 1, fisetin,<xref rid="CIT0008" ref-type="bibr">8</xref>
 solamargine,<xref rid="CIT0009" ref-type="bibr">9</xref>
 and protocatechuic acid<xref rid="CIT0010" ref-type="bibr">10</xref>
 have been reported to increase antitumor efficacy and reduce chemoresistance in NSCLCs.</p>
<p>Programmed cell death is important in determining the fate of a cell under physiological and pathological conditions. Programmed cell death is classified into three categories based on morphological changes:<xref rid="CIT0011" ref-type="bibr">11</xref>
,<xref rid="CIT0012" ref-type="bibr">12</xref>
 apoptosis (type I), autophagic cell death (type II), and necrosis (type III). Apoptosis is characterized by cell shrinkage, loss of adhesion to the extracellular matrix or neighbors, nuclear condensation, and fragmentation.<xref rid="CIT0013" ref-type="bibr">13</xref>
 Autophagy is a catabolic process in which cells succumb to nutrient starvation, damage, and various stresses.<xref rid="CIT0014" ref-type="bibr">14</xref>
 Misfolded proteins and organelles are usually sequestered into autophagosomes and then degraded by lysozyme after the autophagosome fuses with a lysosome.<xref rid="CIT0015" ref-type="bibr">15</xref>
 In contrast, excessive accumulation of autophagic vacuoles in the cytoplasm can induce autophagic cell death<xref rid="CIT0016" ref-type="bibr">16</xref>
–<xref rid="CIT0018" ref-type="bibr">18</xref>
 in a caspase-independent pathway<xref rid="CIT0019" ref-type="bibr">19</xref>
 different from apoptosis or necrosis.<xref rid="CIT0020" ref-type="bibr">20</xref>
,<xref rid="CIT0021" ref-type="bibr">21</xref>
</p>
<p>Oleanolic acid (3β-hydroxyolean-12-en-28-oic acid; OA), a pentacyclic triterpenoid contained in <italic>Salvia glutinosa, Phytolacca americana, Rosa woodsii, Oldenladia diffusa, Kochia scoparia</italic>
, and other plants, is known to have multiple biological activities, such as anti-inflammatory, antiviral, antifungal, hepatoprotective, and antitumor effects.<xref rid="CIT0022" ref-type="bibr">22</xref>
–<xref rid="CIT0024" ref-type="bibr">24</xref>
 The antitumor effect of oleanolic acid has been considered to be limited in several cancers. The present study aimed to explore the underlying antitumor mechanism of methyloleanolate (MO), a derivative of OA, in A549 and H1299 NSCLC cells and to determine MO’s association with apoptotic and autophagic cell death signaling pathways.</p>
</sec>
<sec id="S0002"><title>Materials And Methods</title>
<sec id="S0002-S2001"><title>Reagents And Antibodies</title>
<p>OA and MO (<xref rid="F0001" ref-type="fig">Figure 1</xref>
) were isolated from <italic>Salvia glutinosa</italic>
<xref rid="CIT0025" ref-type="bibr">25</xref>
 by Dr Namin Baek, a pharmacognosist and professor at Kyung Hee University, and purified up to 98% by means of high-performance liquid chromatography. Dulbecco’s Modified Eagle’s Medium, Roswell Park Memorial Institute (RPMI) 1640 medium, and fetal bovine serum (FBS) were purchased from Welgene (Gyeongsan, Korea). 3-Methyladenine (3-MA), N-Acetyl-L-cysteine (NAC), 2′,7′-dichlorofluorescin diacetate (DCF-DA) and β-actin were purchased from Sigma-Aldrich (St Louis, MO, USA). Lipofectamine 2000 reagent was purchased from Invitrogen (Carlsbad, CA, USA). Antibodies for poly (ADP-ribose) polymerase (PARP), caspase-3, caspase-8, FasL, DR4, Bid, mammalian or mechanistic target of rapamycin (mTOR), p-mTOR (Ser2448), SAPK/JNK, p-SAPK/JNK (Thr183/Tyr185), ATG5, ATG7 p62 sequestosome (p62/SQSTM1), and beclin 1 were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies for LCB3B and DR5 were purchased from Novous (San Diego, CA, USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA), respectively. SP600125 and z-VAD-fmk were obtained from Calbiochem (San Diego, CA, USA).<fig id="F0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1</label>
<caption><p>Methyloleanolate (MO) increased apoptosis (indicated by Annexin V/PI staining) more than oleanolate (OA) did in A549 and H1299 non–small cell lung cancer cells. (<bold>A</bold>
) Chemical structure of OA and MO. (<bold>B</bold>
) Apoptotic fraction of OA- or MO-treated A549 and H1299 cells, determined by FACSCalibur with Annexin V/PI staining. A549 and H1299 cells were exposed to OA (50, 100 <inline-formula id="ILM0001"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0001.jpg"></inline-graphic>
<tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 or MO (20, 40 <inline-formula id="ILM0002"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0002.jpg"></inline-graphic>
<tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 for 12 hrs and apoptotic cells were analyzed by FACSCalibur with Annexin V/PI staining. N = 6 per group. Two-way ANOVA with a post-hoc Tukey’s test was used for all the statistical analyses. (<bold>C</bold>
) The effect of OA and MO on the fraction of apoptotic A549 and H1299 cells.</p>
</caption>
<graphic content-type="print-only" xlink:href="OTT-12-8621-g0001"></graphic>
</fig>
</p>
</sec>
<sec id="S0002-S2002"><title>Cell Cultures</title>
<p>Non–small cell lung cancer (NSCLC) cell lines A549 (ATCC<sup>®</sup>
 ccl-185™) and H1299 (ATCC<sup>®</sup>
 CRL-5803™) and normal lung fibroblast HEL299 cells (ATCC<sup>®</sup>
 CCL-137™) were purchased from American Type Culture Collection (Manassas, VA, USA). <italic>ATG5</italic>
<sup>+/+</sup>
 and <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells were obtained from Professor Guillermina Lozano (The University of Texas MD Anderson Cancer Center, USA) and were approved (19–084) by the Living Modified Organism (LMO) committee of Kyung Hee University. The cells were maintained in RPMI 1640 supplemented with 10% FBS (Gibco, Carlsbad, CA, USA), 1% penicillin/streptomycin, and 2 µM L-glutamine (WelGene, Deagu, South Korea) at 37 °C in 5% CO<sub>2</sub>
. The cells were incubated in the growth medium under a humidified, 5% CO<sub>2</sub>
 atmosphere at 37 °C.</p>
</sec>
<sec id="S0002-S2003"><title>Cell Viability Assay</title>
<p>The cytotoxic effects of OA and MO were evaluated by means of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. In brief, A549 and H1299 cells (1 × 10<sup>4</sup>
 cells per well) were seeded onto 96-well culture plates and exposed to various concentrations of OA or MO for 24 or 48 hrs. The cells were incubated with MTT (1 mg/mL) for 2 hrs and then treated with MTT lysis solution for 1 hr. Optical density was measured with a microplate reader (Molecular Devices Co, San Jose, USA) at 570 nm. Cell viability was calculated as the number of viable cells in the groups treated with OA or MO as a percentage of the number of viable cells in the untreated control.</p>
</sec>
<sec id="S0002-S2004"><title>Apoptosis Detection By Annexin V/PI Double Staining</title>
<p>A549 and H1299 cells were exposed to OA (50 or 100 <inline-formula id="ILM0003"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0003.jpg"></inline-graphic>
<tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 or MO (20 or 40 <inline-formula id="ILM0004"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0004.jpg"></inline-graphic>
<tex-math id="M4">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 for 12 hrs, washed with phosphate-buffered saline (PBS), and harvested by trypsinization. The cells were gently resuspended in a binding buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4, 140 mM NaCl, 2.5 mM CaCl<sub>2</sub>
) and incubated with Annexin V-FITC and propidium iodide for 15 mins at room temperature in the dark with the Annexin V-Apoptosis Detection kit (Biovision, Mipitas, USA). Apoptotic cells were analyzed by FACSCalibur (Becton Dickinson, San Jose, USA) and were defined as the number of cells positively stained by Annexin V/PI as apoptotic portion.</p>
</sec>
<sec id="S0002-S2005"><title>Western Blot Analysis</title>
<p>A549 and H1299 cells were seeded onto 60-mm dishes at 5 × 10<sup>5</sup>
 cells per dish in RPMI 1640 with 10% FBS and exposed to OA (50 or 100 <inline-formula id="ILM0005"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0005.jpg"></inline-graphic>
<tex-math id="M5">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 or MO (20 or 40 <inline-formula id="ILM0006"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0006.jpg"></inline-graphic>
<tex-math id="M6">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}}){\ }$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
for 12 hrs. The cells were then washed with cold PBS and harvested by centrifugation. The pellets were lysed in radioimmunoprecipitation assay (RIPA) lysis buffer containing RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, and 1% TritonX-100) containing protease inhibitors (Roche, Basel, Switzerland). Cell lysates were centrifuged at 13,000 rpm for 15 mins at 4 °C, and the supernatant was collected. Protein content was quantified with the DC Protein Assay Kit (Bio-Rad) according to the manufacturer’s instructions. An equal amount of protein (30 μg) was subjected to 10% to 15% sodium dodecyl sulfate and polyacrylamide gel SDS-PAGE) and transferred onto 0.45 μm nitrocellulose membranes. The membranes were blocked with 5% skim milk or 3% Bovine Serum Albumin (BSA) in PBS with 0.1% Tween-20 and incubated with primary antibody at 4 °C. The membranes were washed and incubated with secondary antibodies. Proteins were detected using the enhanced chemiluminescence (ECL) system (Amersham, Buckinghamshire, England) and analyzed by densitometry with Image J (Bethesda, USA) software.</p>
</sec>
<sec id="S0002-S2006"><title>Immunofluorescence Analysis For LC3 Puncta</title>
<p>A549 and H1299 cells were seeded at 5 × 10<sup>4</sup>
 cells onto glass discs, and one disc was placed in each well of 24-well plates and exposed to OA or MO for 12 hrs. The cells were fixed with 4% paraformaldehyde in PBS for 15 mins at room temperature and the discs were treated with 0.01% Triton X-100 for 10 mins and blocked with 2% BSA for 30 mins at room temperature. The cells were incubated with anti-LC3 antibody at 4 °C overnight and cultured with Alexa Fluor 488-conjugated secondary antibody for 1 hr. Nuclear staining was then performed with DAPI (Sigma) and fluorescence images of the cells were observed under a Zeiss LSM 710 microscope (Boston, USA). Also, the number of green fluorescent protein (GFP)-LC3 puncta per cell was counted from randomly selected photographs.</p>
</sec>
<sec id="S0002-S2007"><title>Autophagic Flux Assay With Tandem Sensor Red And Green Fluorescent Protein LC3 Constructs</title>
<p>To investigate whether autophagy flux was impaired by MO, an autophagy flux assay was conducted. A549 and H1299 cells were transfected with tandem sensor LC3 conjugated to red fluorescent protein and green fluorescent protein (RFP-GFP-LC3) constructs (a gift from Professor Hongbo Hu from the Department of Nutrition and Health, College of Food Science and Nutritional Engineering, China Agricultural University) by a transient transfection method using Lipofectamine 2000 (Thermo Fisher Scientific, New York, USA). The cells were then exposed to 40 µM MO for 12 hrs. Then, the merged red or green channel signals were observed in MO-treated A549 and H1299 cells under the Zeiss LSM 710 confocal microscope.</p>
</sec>
<sec id="S0002-S2008"><title>RNA Interference</title>
<p>A549 and H1299 cells were transfected with scrambled siRNA or DR5 siRNA plasmids with Lipofectamine 2000 and InterferinTM transfection reagent (Polyplus-transfection Inc, New York, NY, USA). The mixtures of DR5 siRNA (40 nM) and transfection reagent were incubated for 10 mins and then the cells were incubated at 37 °C for 48 hrs before exposure to MO (40 <inline-formula id="ILM0007"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0007.jpg"></inline-graphic>
<tex-math id="M7">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 for 12 hrs.</p>
</sec>
<sec id="S0002-S2009"><title>Measurement Of Reactive Oxygen Species Production</title>
<p>A549 and H1299 cells were seeded at 3 × 10<sup>5</sup>
 per well in 6-well plates in a phenol red–free RPMI 1640 with 10% FBS. The cells were pretreated with or without NAC for 1 hr and then exposed to MO (10, 20, 30, or 40 <inline-formula id="ILM0008"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0008.jpg"></inline-graphic>
<tex-math id="M8">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 for 12 hrs. After incubation, fluorescent 2ʹ,7ʹ –dichlorofluorescin diacetate (DCF-DA) was added at 37 °C for 30 mins before cells were harvested. Reactive oxygen species (ROS) production was analyzed by means of flow cytometry and confocal microscopy.</p>
</sec>
<sec id="S0002-S2010"><title>Statistical Analysis</title>
<p>Values were presented as the mean plus or minus standard deviation. Statistical significance was evaluated by Student’s <italic>t-</italic>
test using SigmaPlot software (Systat Software Inc, San Jose, USA) or ANOVA followed by Tukey post-hoc test when the F statistic was significant. <italic>P</italic>
 < 0.05 was considered statistically significant. At least three independent experiments were performed in duplicate for each assay.</p>
</sec>
</sec>
<sec id="S0003"><title>Results</title>
<sec id="S0003-S2001"><title>Effect Of MO On The Fraction Of Apoptotic Cells In A549 And H1299 Non–Small Cell Lung Cancer Cells</title>
<p>To compare the apoptotic effect of MO and OA (<xref rid="F0001" ref-type="fig">Figure 1A</xref>
), a flow cytometry assay with Annexin V/PI staining was conducted on A549 and H1299 NSCLC cells. MO increased the fraction of apoptotic A549 and H1299 cells at concentrations of 20 and 40 μM, while OA only weakly increased the fraction of apoptotic cells even at 50 and 100 μM (<xref rid="F0001" ref-type="fig">Figure 1B</xref>
 and <xref rid="F0001" ref-type="fig">C</xref>
). But MO and OA showed weak cytotoxicity in normal lung fibroblast HEL 299 cells (<underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=211904.pdf">Supplementary Figure 1</ext-link>
</underline>
).</p>
</sec>
<sec id="S0003-S2002"><title>Effect Of MO On Extrinsic Apoptosis Through DR5 Activation In A549 And H1299 Cells</title>
<p>To determine whether the cytotoxic effect of MO is due to apoptosis induction, Western blotting was performed on A549 and H1299 cells. MO markedly activated caspase-8 and caspase-3 and cleaved PARP in MO-treated A549 and H1299 cells (<xref rid="F0002" ref-type="fig">Figure 2A</xref>
), while DR5 was upregulated and no effect was seen on FasL, DR4, and tBid (<xref rid="F0002" ref-type="fig">Figure 2B</xref>
). However, pretreatment with pancaspase inhibitor z-VAD-fmk or knockdown of DR5 reduced cytotoxicity and cleavage of PARP and caspase-3 in MO-treated A549 and H1299 cells (<xref rid="F0002" ref-type="fig">Figure 2C</xref>
 and <xref rid="F0002" ref-type="fig">D</xref>
).<fig id="F0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label>
<caption><p>Methyloleanolate (MO) induced cell death by activation of caspase-3 and caspase-8 and death receptor 5 (DR5) more than oleanolate (OA) did in A549 and H1299 non–small cell lung cancer cells. (<bold>A</bold>
) Effect of OA or MO on caspase-8, cleaved caspase-3, and PARP in A549 and H1299 cells. The cells were treated with OA (50, 100 <inline-formula id="ILM0009"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0009.jpg"></inline-graphic>
<tex-math id="M9">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 or MO (20, 40 <inline-formula id="ILM0010"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0010.jpg"></inline-graphic>
<tex-math id="M10">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 for 12 hrs and subjected to Western blotting with antibodies of caspase-8, caspase-3, cleaved PARP, and β actin. (<bold>B</bold>
) Effect of OA or MO on FASL, DR4, DR5, and Bid in A549 and H1299 cells. (<bold>C</bold>
) Effect of pancaspase inhibitor z-VAD-fmk on PARP cleavage in MO-treated A549 and H1299 cells. (<bold>D</bold>
) Effect of pancaspase inhibitor z-VAD-fmk on the viability of A549 and H1299 cells in the presence or absence of MO or doxorubicin (Dox). (<bold>E</bold>
) Effect of DR5 depletion on DR5, caspase-8, caspase-3, and PARP in MO-treated A549 and H1299 cells. Cells were transfected with control or DR5 siRNA plasmids with or without MO (40 μM) for 12 hrs and subjected to Western blotting with antibodies of DR5, caspase-8, caspase-3, PARP, and β actin.</p>
</caption>
<graphic content-type="print-only" xlink:href="OTT-12-8621-g0002"></graphic>
</fig>
</p>
</sec>
<sec id="S0003-S2003"><title>Effect Of MO On Autophagy In A549 And H1299 Cells</title>
<p>Based on findings that OA can induce protective autophagy in A549 cells<xref rid="CIT0026" ref-type="bibr">26</xref>
 at 100 µg/mL, the effect of MO on autophagy was evaluated in A549 and H1299 cells. MO increased LC3B-II accumulation in a concentration- and time-dependent manner without significant effect on p62 in A549 and H1299 cells more than OA did (<xref rid="F0003" ref-type="fig">Figure 3A</xref>
 and <xref rid="F0003" ref-type="fig">B</xref>
). MO consistently enhanced the formation of GFP-LC3 puncta and autophagic vacuoles more than OA did in A549 and H1299 cells (<xref rid="F0003" ref-type="fig">Figure 3C</xref>
, <underline><ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/get_supplementary_file.php?f=211904.pdf">Supplementary Figure 2</ext-link>
</underline>
).<fig id="F0003" fig-type="figure" orientation="portrait" position="float"><label>Figure 3</label>
<caption><p>Methyloleanolate (MO) induced 1A/1B-light chain 3BII (LC3BII) conversion and puncta in A549 and H1299 cells better than oleanolate (OA) did. (<bold>A</bold>
) Effect of OA and MO on LC3BII and p62/SQSTM1 in A549 and H1299 cells. Cells were incubated with OA (50, 100 <inline-formula id="ILM0011"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0011.jpg"></inline-graphic>
<tex-math id="M11">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 or MO (20, 40 <inline-formula id="ILM0012"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0012.jpg"></inline-graphic>
<tex-math id="M12">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}}){\ }$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
for 12 hrs, and Western blotting was performed. (<bold>B</bold>
) Time-dependent effect of OA (100 <inline-formula id="ILM0013"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0013.jpg"></inline-graphic>
<tex-math id="M13">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 or MO (40 <inline-formula id="ILM0014"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0014.jpg"></inline-graphic>
<tex-math id="M14">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}}){\ }$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
on LC3BII accumulation for 6 hrs, 12 hrs, and 24 hrs in A549 and H1299 cells. (<bold>C</bold>
) Effect of OA and MO on LC3 puncta in A549 and H1299 cells. Immunofluorescence shows that OA (100 μM) or MO (40 μM) formed LC3 puncta in A549 and H1299 cells. The fluorescence images were taken by confocal microscopy. LC3 puncta were counted as means ±SD from three independent experiments. **<italic>P</italic>
 < 0.01 between OA- and MO-treated groups. Bar: 10 μm.</p>
</caption>
<graphic content-type="print-only" xlink:href="OTT-12-8621-g0003"></graphic>
</fig>
</p>
</sec>
<sec id="S0003-S2004"><title>Effect Of MO On Incomplete Autophagy Flux In A549 And H1299 Cells</title>
<p>To evaluate whether the elevation of LC3 lipidation induced by MO was due to fusion with autolysosomes or increased degradation, an autophagy flux assay was conducted in A549 and H1299 cells transfected with RFP-GFP-LC3 constructs. As shown in <xref rid="F0004" ref-type="fig">Figure 4A</xref>
, immunofluorescence revealed the merged yellow color in MO-treated A549 and H1299 cells, whereas more red puncta were observed in OA-treated A549 and H1299 cells. Of note, an early stage autophagy inhibitor, 3-MA, did not significantly affect the cytotoxicity and weakly attenuated the expression of LC3BII in MO-treated A549 and H1299 cells (<xref rid="F0004" ref-type="fig">Figure 4B</xref>
 and C), while a late-stage autophagy inhibitor, chloroquine (CQ), enhanced the cytotoxicity of MO in A549 and H1299 cells (<xref rid="F0004" ref-type="fig">Figure 4D</xref>
).<fig id="F0004" fig-type="figure" orientation="portrait" position="float"><label>Figure 4</label>
<caption><p>Methyloleanolate (MO)-impaired autophagy flux in A549 and H1299 cells. (<bold>A</bold>
) Effect of oleanolate (OA) and MO on autophagy flux in A549 and H1299 cells. A549 and H1299 cells were transfected with LC3 conjugated to red fluorescent protein and green fluorescent protein constructs and exposed to OA (100 μM) or MO (40 μM) for 12 hrs. Autophagy flux was evaluated with confocal microscopy. (<bold>B</bold>
) Effect of 3-methyladenine (3-MA) on 1A/1B-light chain 3BII (LC3BII) and p62/SQSTM1 in OA- or MO-treated A549 and H1299 cells. The cells were pretreated with 3-MA for 1 hr and incubated with OA (100 μM) or MO (40 μM) for 12 hrs. Then western botting was conducted and antibodies of LC3BII and p62/SQSTM1 were used for detection. (<bold>C</bold>
) Effect of 3-MA on the viability of OA- or MO-treated A549 and H1299 cells. The cells were pretreated with 3-MA for 1 hr, exposed to OA (100 μM) or MO (40 μM) for 12 hrs, and an MTT assay was performed. (<bold>D</bold>
) Effect of chloroquine (CQ) on the viability of MO-treated A549 and H1299 cells. The cells were pretreated with CQ for 1 hr and exposed to MO (40 μM) for 12 hrs and a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed. Data are shown as means ±SD from three independent experiments. **<italic>P</italic>
 < 0.01 between CQ- and MO-treated groups. N = 6 per group.</p>
<p><bold>Abbreviation:</bold>
 NS, not significant.</p>
</caption>
<graphic content-type="print-only" xlink:href="OTT-12-8621-g0004"></graphic>
</fig>
</p>
</sec>
<sec id="S0003-S2005"><title>Effect Of MO On ATG5-Dependent Autophagy In A549 And H1299 Cells</title>
<p>To elucidate the mechanism of MO-induced autophagy, the effect of MO on beclin 1, ATG5, and ATG7 was examined in A549 and H1299 cells. Interestingly, MO attenuated the expression of beclin 1 and ATG7 but increased the expression of ATG5 in A549 and H1299 cells more than OA did (<xref rid="F0005" ref-type="fig">Figure 5A</xref>
). Furthermore, MO reduced the expression of beclin 1 in a time-dependent fashion in A549 and H1299 cells (<xref rid="F0005" ref-type="fig">Figure 5B</xref>
). To confirm the role of ATG5 in MO-induced autophagy, Western blotting was performed in <italic>ATG5</italic>
<sup>+/+</sup>
 and <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells. As shown in <xref rid="F0005" ref-type="fig">Figure 5C</xref>
, MO induced LC3II conversion and upregulation of ATG5 in <italic>ATG5</italic>
<sup>+/+</sup>
 MEF cells but it did not in <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells.<fig id="F0005" fig-type="figure" orientation="portrait" position="float"><label>Figure 5</label>
<caption><p>Autophagy-related gene 5 (<italic>ATG5</italic>
) plays a critical role in methyloleanolate (MO)-induced autophagy in A549 and H1299 cells. (<bold>A</bold>
) Concentration-dependent effect of oleanolate (OA) or MO on beclin 1, ATG5 and ATG7 in A549 and H1299 cells. Cells were incubated with OA (50, 100 µM) or MO (20, 40 µM) for 12 hrs and subjected to Western blotting and antibodies of beclin 1, ATG5, and ATG7 were used for detection. (<bold>B</bold>
) Time-dependent effect of MO (40 μM) on beclin 1 and 1A/1B-light chain 3BII (LC3BII) in A549 and H1299 cells. (<bold>C</bold>
) Effect of endogenous ATG5 on beclin 1, LC3BII, and ATG5 in <italic>ATG5</italic>
<sup>+/+</sup>
 or <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells. <italic>ATG5</italic>
<sup>+/+</sup>
 or <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells were treated with MO (40 μM) for 12 hrs and Western blotting was performed with LC3BII and ATG5 antibodies.</p>
</caption>
<graphic content-type="print-only" xlink:href="OTT-12-8621-g0005"></graphic>
</fig>
</p>
</sec>
<sec id="S0003-S2006"><title>Effect Of ROS Generation On MO-Induced Autophagy In A549 And H1299 Cells</title>
<p>Emerging evidence shows that ROS play a critical role in apoptotic and autophagic cell death.<xref rid="CIT0012" ref-type="bibr">12</xref>
,<xref rid="CIT0027" ref-type="bibr">27</xref>
–<xref rid="CIT0029" ref-type="bibr">29</xref>
 To confirm whether MO is associated with ROS generation, ROS production was measured by flow cytometric analysis with DCFDA staining in A549 and H1299 cells. MO significantly induced ROS production in a concentration- and time-dependent manner (<xref rid="F0006" ref-type="fig">Figure 6A</xref>
 and <xref rid="F0006" ref-type="fig">B</xref>
). Conversely, ROS inhibitor NAC suppressed the number of green fluorescent ROS particles observed by immunofluorescence after DCFDA staining (<xref rid="F0006" ref-type="fig">Figure 6C</xref>
). ROS inhibitor NAC blocked phosphorylation of c-Jun N-terminal kinases (JNK), activation of DR5, LC3BII conversion, and PARP cleavage induced by MO in A549 and H1299 cells (<xref rid="F0006" ref-type="fig">Figure 6D</xref>
). NAC consistently suppressed cytotoxicity and LC3 puncta by MO in A549 and H1299 cells (<xref rid="F0006" ref-type="fig">Figure 6E</xref>
 and <xref rid="F0006" ref-type="fig">F</xref>
).<fig id="F0006" fig-type="figure" orientation="portrait" position="float"><label>Figure 6</label>
<caption><p>Reactive oxygen species (ROS) mediate cytotoxicity and cell death induced by methyloleanolate (MO) in H1299 cells. (<bold>A</bold>
) Effect of MO on ROS production in H1299 cells. ROS level was measured as DCFDA by flow cytometry in H1299 cells treated with various concentrations of MO (10, 20, 30, 40 μM) for 12 hrs. (<bold>B</bold>
) Time-dependent effect of MO on ROS production in H1299 cells. The cells were exposed to 40 μM MO for 6 and 12 hrs, and ROS production was analyzed by flow cytometry after DCFDA staining for 30 mins. (<bold>C</bold>
) ROS were generated by MO (40 μM) with or without N-acetyl-L-cysteine (NAC) by using DCFDA, and the green fluorescence images were analyzed by fluorescence microscopy. (<bold>D</bold>
) Effect of NAC on pJNK DR5, LC3BII, and c-PARP in A549 and H1299 cells. Cells were treated with MO (40 μM) for 12 hrs, after pretreatment with 4 mM NAC, and subjected to Western blotting with p-JNK, JNK, DR5, LC3BII, and cleaved PARP antibodies. (<bold>E</bold>
) Effect of NAC on LC3 puncta in MO-treated H1299 cells. H1299 cells were exposed to MO (40 μM) for 12 hrs and LC3B puncta were detected by confocal microscopy. **<italic>P</italic>
 <0.01 versus control. Bar: 10 μm. (<bold>F</bold>
) Effect of NAC on the viability of MO-treated A549 and H1299 cells. Cells were exposed to MO (40 μM) for 12 hrs and a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed. Results represent means ±SD from three independent experiments. **<italic>P</italic>
 < 0.01 versus control. N = 6 per group.</p>
</caption>
<graphic content-type="print-only" xlink:href="OTT-12-8621-g0006"></graphic>
</fig>
</p>
</sec>
<sec id="S0003-S2007"><title>Effect Of JNK On MO-Induced Autophagy In A549 And H1299 Cells</title>
<p>It is well documented that JNK and the mammalian or mechanistic target of rapamycin (mTOR) play crucial roles in autophagy induction.<xref rid="CIT0030" ref-type="bibr">30</xref>
–<xref rid="CIT0032" ref-type="bibr">32</xref>
 Here, Western blots revealed that MO weakly attenuated the expression of mTOR and remarkably activated the phosphorylation of JNK in a time- and concentration-dependent fashion more than OA did in A549 and H1299 cells (<xref rid="F0007" ref-type="fig">Figure 7A</xref>
). Conversely, JNK inhibitor SP600125 blocked phosphorylation of JNK, LC3BII accumulation, DR5 activation, and PARP cleavage induced by MO in A549 and H1299 cells (<xref rid="F0007" ref-type="fig">Figure 7B</xref>
). SP600125 consistently reduced the number of LC3 puncta and cytotoxicity by MO in H1299 cells (<xref rid="F0007" ref-type="fig">Figure 7C</xref>
 and <xref rid="F0007" ref-type="fig">D</xref>
).<fig id="F0007" fig-type="figure" orientation="portrait" position="float"><label>Figure 7</label>
<caption><p>Pivotal role of c-Jun N-terminal kinases (JNK) in cytotoxicity, and apoptotic and autophagic cell death in MO-treated A549 and H1299 cells. (<bold>A</bold>
) Effect of oleanolate (OA) and methyloleanolate (MO) on p-mTOR and p-JNK in A549 and in H1299 cells. Cell were exposed to OA (50, 100 <inline-formula id="ILM0015"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0015.jpg"></inline-graphic>
<tex-math id="M15">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}})$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
 or MO (20, 40 <inline-formula id="ILM0016"><alternatives><inline-graphic xlink:href="OTT-12-8621-e0016.jpg"></inline-graphic>
<tex-math id="M16">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{\mu M}}){\ }$$
\end{document}</tex-math>
</alternatives>
</inline-formula>
for 12 hrs and subjected to Western blotting with antibodies of p-mTOR, mTOR, p-JNK, JNK, and β actin. (<bold>B</bold>
) Effect of JNK inhibitor SP600125 on p-JNK LC3BII, DR5, and c-PARP in A549 and in H1299 cells. Cell were exposed to dimethyl sulfoxide (DMSO) or MO (40 μM) for 12 hrs and subjected to Western blotting with antibodies of p-mTOR, mTOR, p-JNK, JNK, LC3BII, DR5, c-PARP, and β actin in the presence or absence of SP600125. (<bold>C</bold>
) Effect of SP600125 on LC3 puncta in H1299 cells. H1299 cells were exposed to MO (40 μM) with or without SP600125 for 12 hrs and were stained by LC3 antibody. Immunofluorescence images for LC3 puncta were detected by confocal microscopy. LC3 puncta were counted as means ±SD from three independent experiments. **<italic>P</italic>
 < 0.01, versus control. Bar: 10 μm. (<bold>D</bold>
) Effect of SP600125 on the viability of MO-treated H1299 cells. Cell viability was determined in MO- (40 μM) treated H1299 cells with or without SP690125 by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Results represent means ±SD from three independent experiments. *<italic>P</italic>
 < 0.05, versus control. N = 6 per group.</p>
</caption>
<graphic content-type="print-only" xlink:href="OTT-12-8621-g0007"></graphic>
</fig>
</p>
</sec>
</sec>
<sec id="S0004"><title>Discussion</title>
<p>Lung cancer has a high death rate because it is difficult to detect at an early stage and thus has often metastasized to other organ tissues before it is diagnosed and treated.<xref rid="CIT0033" ref-type="bibr">33</xref>
 In the current study, the underlying antitumor mechanism of MO was comparatively assessed in A549 and H1299 NSCLCs with OA. There have been no previous reports on the antitumor effect of MO, although there have been reports on its antidiabetic activity.<xref rid="CIT0034" ref-type="bibr">34</xref>
 The results of this study showed that MO increased the fraction of Annexin V/PI–positive apoptotic cells and activated caspases (8 and 3) and DR5 in A549 and H1299 cells, and did not affect Bid. This implies that MO has an extrinsic apoptotic effect in NSCLCs. Pancaspase inhibitor z-VAD-fmk consistently reduced the cytotoxicity and cleavage of PARP and caspase-3. DR5 knockdown also attenuated the cleavage of PARP and caspase-8 and caspase-3 in MO-treated A549 and H1299 cells, which indicates that the cytotoxicity of MO mainly occurs via an extrinsic apoptosis signaling pathway.</p>
<p>Interestingly, MO induced autophagic features in A549 and H1299 cells, including LC3BII accumulation and puncta, along with autophagosomes and vacuoles (observed by transmission electron microscopy). These results may indicate that MO causes autophagic cell death, because excessive accumulation of autophagic vacuoles in the cytoplasm may indicate hyperactivation of autophagy which can lead to autophagic cell death.<xref rid="CIT0016" ref-type="bibr">16</xref>
–<xref rid="CIT0018" ref-type="bibr">18</xref>
 However, the effects of different concentrations of MO may be complex. Research has shown that low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis.<xref rid="CIT0035" ref-type="bibr">35</xref>
 In addition, low concentrations of nonsteroidal anti-inflammatory drugs can induce autophagy at early stages, whereas higher concentrations of nonsteroidal anti-inflammatory drugs can inhibit autophagy and induce apoptosis at later stages.<xref rid="CIT0036" ref-type="bibr">36</xref>
 In light of these results, further study on the effect of MO on autophagy and apoptosis at low and high concentrations is warranted.</p>
<p>Autophagy is a catabolic process consisting of four distinct steps, initiation, nucleation, elongation, and degradation, which are regulated by autophagy-related genes (<italic>ATG</italic>
s).<xref rid="CIT0037" ref-type="bibr">37</xref>
 Among the ATG proteins, autophagy-related gene 5 (<italic>ATG5</italic>
) is one of the key regulators of autophagic cell death,<xref rid="CIT0038" ref-type="bibr">38</xref>
 while ATG6 and beclin 1 have multiple functions are not autophagy-specific<xref rid="CIT0039" ref-type="bibr">39</xref>
 and ATG7 is an important protein in the elongation of the autophagosome membranes.<xref rid="CIT0040" ref-type="bibr">40</xref>
 The results reported here show that MO attenuated the expression of mTOR, but activated <italic>ATG5</italic>
 in A549 and H1299 cells. However, depletion or overexpression of ATG6 or beclin 1 did not affect LC3BII accumulation in A549 and H1299 cells (data not shown). In contrast, MO-induced LC3BII accumulation in <italic>ATG5</italic>
<sup>+/+</sup>
 MEF cells but not in <italic>ATG5</italic>
<sup>−/-</sup>
 MEF cells, which indicates the pivotal role of ATG5 in the MO-induced autophagic effect in A549 and H1299 cells.</p>
<p>Emerging evidence reveals that autophagy has dual effects: it can have a cytoprotective effect on healthy cells and can cause autophagic cell death in cancer cells.<xref rid="CIT0041" ref-type="bibr">41</xref>
–<xref rid="CIT0044" ref-type="bibr">44</xref>
 To confirm the exact autophagic mechanism of MO, an autophagy flux assay and an autophagy inhibitor study were carried out in the current study. Immunofluorescence revealed a yellowish color in MO-treated A549 and H1299 cells transfected with RFP-GFP-LC3 constructs, which indicates incomplete autophagy because the green fluorescent protein fluorescence was not reduced under the acidic lysosomal environment. Furthermore, early-stage autophagy inhibitor 3-MA did not significantly affect the cytotoxicity and protein expression of LC3BII and p62/SQSTM-1, whereas late-stage autophagy inhibitor CQ enhanced the cytotoxicity of MO in A549 and H1299 cells. This implies that the cytotoxicity of MO is mainly caused by autophagic cell death via autophagosome accumulation, which occurs despite the impaired autophagy process in A549 and H1299 cells.</p>
<p>There is accumulating evidence that excessive ROS generation can be toxic and induce cell death.<xref rid="CIT0045" ref-type="bibr">45</xref>
 Herein, MO significantly induced ROS production in a concentration- and time-dependent fashion and ROS inhibitor NAC blocked cytotoxicity, PARP cleavage, and LC3BII accumulation with puncta and activation of p-JNK and DR5 induced by MO in A549 and H1299 cells. This demonstrates the crucial role of ROS in activating p-JNK in MO-induced apoptotic and autophagic cell death in NSCLCs. Similarly, Song et al<xref rid="CIT0046" ref-type="bibr">46</xref>
 revealed that OA derivative SZC017 induced ROS-dependent apoptosis in A549 cells through inactivation of Akt and JAK2/STAT3 signaling.</p>
<p>It is well documented that transient activated JNK is associated with cell survival, sustained JNK activation induces apoptosis,<xref rid="CIT0047" ref-type="bibr">47</xref>
 and chemoresistance is acquired through autophagy mediated by JNK and mTOR pathways.<xref rid="CIT0045" ref-type="bibr">45</xref>
,<xref rid="CIT0048" ref-type="bibr">48</xref>
,<xref rid="CIT0049" ref-type="bibr">49</xref>
 Our study showed that MO-induced phosphorylation of JNK in A549 and H1299 cells. Conversely, JNK inhibitor SP600125 blocked cytotoxicity, PARP cleavage, LC3BII accumulation with puncta and activation of p-JNK and DR5 induced by MO in A549 and H1299 cells, which indicates a critical role of p-JNK in MO-induced apoptotic and autophagic cell death in NSCLCs. Similarly, Liu et al<xref rid="CIT0050" ref-type="bibr">50</xref>
 demonstrated OA-induced apoptosis in A549 cells via activation of ROS/ASK1/p38 MAPK pathways, but not JNK signaling. Further in vitro, in vivo, and clinical studies are required to elucidate the detailed mechanisms, pharmacokinetics, and toxicology of MO, especially given that MO showed better anticancer potential in NSCLC cells than OA did.</p>
</sec>
<sec id="S0005"><title>Conclusion</title>
<p>MO increased the fraction of Annexin V/PI apoptotic cells, activated caspase-3, caspase-8, DR5, ATG5, p-JNK, and ROS production, and induced autophagic features of LC3BII conversion. NAC and JNK inhibitor SP600125 blocked the apoptotic and autophagic cell death by MO in A549 and H1299 cells. Overall, the findings reported here suggest that MO induces apoptotic and autophagic cell death in NSCLC cells more effectively than OA does through ROS generation and JNK phosphorylation.</p>
</sec>
</body>
<back><ack><title>Acknowledgments</title>
<p>We thank the Kim lab members for active discussion and suggestions. The work reported here was supported by the National Research Foundation of Korea Grant funded by the Korean Government (no. 2017R1A2A1A17069297).</p>
</ack>
<sec id="S0006"><title>Author Contributions</title>
<p>All authors contributed to data analysis, drafting or revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.</p>
</sec>
<sec id="S0007" sec-type="COI-statement"><title>Disclosure</title>
<p>The authors report no conflicts of interest in this work.</p>
</sec>
<ref-list><title>References</title>
<ref id="CIT0001"><label>1.</label>
<mixed-citation publication-type="journal"><string-name><surname>Torre</surname>
<given-names>LA</given-names>
</string-name>
, <string-name><surname>Bray</surname>
<given-names>F</given-names>
</string-name>
, <string-name><surname>Siegel</surname>
<given-names>RL</given-names>
</string-name>
, <string-name><surname>Ferlay</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Lortet‐Tieulent</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Jemal</surname>
<given-names>A</given-names>
</string-name>
. <article-title>Global cancer statistics, 2012</article-title>
. <source><italic toggle="yes">CA</italic>
</source>
. <year>2015</year>
;<volume>65</volume>
(<issue>2</issue>
):<fpage>87</fpage>
–<lpage>108</lpage>
. doi:<pub-id pub-id-type="doi">10.3322/caac.21262</pub-id>
<pub-id pub-id-type="pmid">25651787</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0002"><label>2.</label>
<mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>C</given-names>
</string-name>
, <string-name><surname>Yao</surname>
<given-names>LD</given-names>
</string-name>
. <article-title>Strategies to improve outcomes of patients with EGRF-mutant non-small cell lung cancer: review of the literature</article-title>
. <source><italic toggle="yes">J Thorac Oncol</italic>
</source>
. <year>2016</year>
;<volume>11</volume>
(<issue>2</issue>
):<fpage>174</fpage>
–<lpage>186</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.jtho.2015.10.002</pub-id>
<pub-id pub-id-type="pmid">26845114</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0003"><label>3.</label>
<mixed-citation publication-type="journal"><string-name><surname>Shi</surname>
<given-names>SB</given-names>
</string-name>
, <string-name><surname>Wang</surname>
<given-names>M</given-names>
</string-name>
, <string-name><surname>Tian</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>R</given-names>
</string-name>
, <string-name><surname>Chang</surname>
<given-names>CX</given-names>
</string-name>
, <string-name><surname>Qi</surname>
<given-names>JL</given-names>
</string-name>
. <article-title>MicroRNA 25, microRNA 145, and microRNA 210 as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations</article-title>
. <source><italic toggle="yes">Transl Res</italic>
</source>
. <year>2016</year>
;<volume>170</volume>
:<fpage>1</fpage>
–<lpage>7</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.trsl.2015.11.006</pub-id>
<pub-id pub-id-type="pmid">26687391</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0004"><label>4.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>Z</given-names>
</string-name>
, <string-name><surname>Yao</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Tan</surname>
<given-names>B</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Chen</surname>
<given-names>B</given-names>
</string-name>
. <article-title>Detection of microRNA-200b may predict the inhibitory effect of gefitinib on non-small cell lung cancer and its potential mechanism</article-title>
. <source><italic toggle="yes">Oncol Lett</italic>
</source>
. <year>2016</year>
;<volume>12</volume>
(<issue>6</issue>
):<fpage>5349</fpage>
–<lpage>5355</lpage>
. doi:<pub-id pub-id-type="doi">10.3892/ol.2016.5365</pub-id>
<pub-id pub-id-type="pmid">28101246</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0005"><label>5.</label>
<mixed-citation publication-type="journal"><string-name><surname>Paez</surname>
<given-names>JG</given-names>
</string-name>
, <string-name><surname>Janne</surname>
<given-names>PA</given-names>
</string-name>
, <string-name><surname>Lee</surname>
<given-names>JC</given-names>
</string-name>
, et al. <article-title>EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy</article-title>
. <source><italic toggle="yes">Science</italic>
</source>
. <year>2004</year>
;<volume>304</volume>
(<issue>5676</issue>
):<fpage>1497</fpage>
–<lpage>1500</lpage>
. doi:<pub-id pub-id-type="doi">10.1126/science.1099314</pub-id>
<pub-id pub-id-type="pmid">15118125</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0006"><label>6.</label>
<mixed-citation publication-type="journal"><string-name><surname>You</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Shou</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Deng</surname>
<given-names>D</given-names>
</string-name>
, et al. <article-title>Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines</article-title>
. <source><italic toggle="yes">Oncotarget</italic>
</source>
. <year>2015</year>
;<volume>6</volume>
(<issue>37</issue>
):<fpage>40268</fpage>
–<lpage>40282</lpage>
. doi:<pub-id pub-id-type="doi">10.18632/oncotarget.5592</pub-id>
<pub-id pub-id-type="pmid">26384345</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0007"><label>7.</label>
<mixed-citation publication-type="journal"><string-name><surname>Hsu</surname>
<given-names>HS</given-names>
</string-name>
, <string-name><surname>Huang</surname>
<given-names>PI</given-names>
</string-name>
, <string-name><surname>Chang</surname>
<given-names>YL</given-names>
</string-name>
, et al. <article-title>Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells</article-title>
. <source><italic toggle="yes">Cancer</italic>
</source>
. <year>2011</year>
;<volume>117</volume>
(<issue>13</issue>
):<fpage>2970</fpage>
–<lpage>2985</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/cncr.25869</pub-id>
<pub-id pub-id-type="pmid">21225866</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0008"><label>8.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kang</surname>
<given-names>KA</given-names>
</string-name>
, <string-name><surname>Piao</surname>
<given-names>MJ</given-names>
</string-name>
, <string-name><surname>Hyun</surname>
<given-names>JW</given-names>
</string-name>
. <article-title>Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway</article-title>
. <source><italic toggle="yes">In Vitro Cell Dev Biol Anim</italic>
</source>
. <year>2015</year>
;<volume>51</volume>
(<issue>3</issue>
):<fpage>300</fpage>
–<lpage>309</lpage>
. doi:<pub-id pub-id-type="doi">10.1007/s11626-014-9830-6</pub-id>
<pub-id pub-id-type="pmid">25381036</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0009"><label>9.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liang</surname>
<given-names>CH</given-names>
</string-name>
, <string-name><surname>Shiu</surname>
<given-names>LY</given-names>
</string-name>
, <string-name><surname>Chang</surname>
<given-names>LC</given-names>
</string-name>
, <string-name><surname>Sheu</surname>
<given-names>HM</given-names>
</string-name>
, <string-name><surname>Tsai</surname>
<given-names>EM</given-names>
</string-name>
, <string-name><surname>Kuo</surname>
<given-names>KW</given-names>
</string-name>
. <article-title>Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin</article-title>
. <source><italic toggle="yes">Chem Res Toxicol</italic>
</source>
. <year>2008</year>
;<volume>21</volume>
(<issue>2</issue>
):<fpage>393</fpage>
–<lpage>399</lpage>
. doi:<pub-id pub-id-type="doi">10.1021/tx700310x</pub-id>
<pub-id pub-id-type="pmid">18078328</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0010"><label>10.</label>
<mixed-citation publication-type="journal"><string-name><surname>Tsao</surname>
<given-names>SM</given-names>
</string-name>
, <string-name><surname>Hsia</surname>
<given-names>TC</given-names>
</string-name>
, <string-name><surname>Yin</surname>
<given-names>MC</given-names>
</string-name>
. <article-title>Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF-kappaB pathways</article-title>
. <source><italic toggle="yes">Nutr Cancer</italic>
</source>
. <year>2014</year>
;<volume>66</volume>
(<issue>8</issue>
):<fpage>1331</fpage>
–<lpage>1341</lpage>
. doi:<pub-id pub-id-type="doi">10.1080/01635581.2014.956259</pub-id>
<pub-id pub-id-type="pmid">25356681</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0011"><label>11.</label>
<mixed-citation publication-type="journal"><string-name><surname>Clarke</surname>
<given-names>PG</given-names>
</string-name>
. <article-title>Developmental cell death: morphological diversity and multiple mechanisms</article-title>
. <source><italic toggle="yes">Anat Embryol (Berl)</italic>
</source>
. <year>1990</year>
;<volume>181</volume>
(<issue>3</issue>
):<fpage>195</fpage>
–<lpage>213</lpage>
. doi:<pub-id pub-id-type="doi">10.1007/bf00174615</pub-id>
<pub-id pub-id-type="pmid">2186664</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0012"><label>12.</label>
<mixed-citation publication-type="journal"><string-name><surname>Baehrecke</surname>
<given-names>EH</given-names>
</string-name>
. <article-title>How death shapes life during development</article-title>
. <source><italic toggle="yes">Nat Rev Mol Cell Biol</italic>
</source>
. <year>2002</year>
;<volume>3</volume>
(<issue>10</issue>
):<fpage>779</fpage>
–<lpage>787</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/nrm931</pub-id>
<pub-id pub-id-type="pmid">12360194</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0013"><label>13.</label>
<mixed-citation publication-type="journal"><string-name><surname>Nishida</surname>
<given-names>K</given-names>
</string-name>
, <string-name><surname>Yamaguchi</surname>
<given-names>O</given-names>
</string-name>
, <string-name><surname>Otsu</surname>
<given-names>K</given-names>
</string-name>
. <article-title>Crosstalk between autophagy and apoptosis in heart disease</article-title>
. <source><italic toggle="yes">Circ Res</italic>
</source>
. <year>2008</year>
;<volume>103</volume>
(<issue>4</issue>
):<fpage>343</fpage>
–<lpage>351</lpage>
. doi:<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.175448</pub-id>
<pub-id pub-id-type="pmid">18703786</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0014"><label>14.</label>
<mixed-citation publication-type="journal"><string-name><surname>Towers</surname>
<given-names>CG</given-names>
</string-name>
, <string-name><surname>Thorburn</surname>
<given-names>A</given-names>
</string-name>
. <article-title>Therapeutic targeting of autophagy</article-title>
. <source><italic toggle="yes">EBioMedicine</italic>
</source>
. <year>2016</year>
. doi:<pub-id pub-id-type="doi">10.1016/j.ebiom.2016.10.034</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0015"><label>15.</label>
<mixed-citation publication-type="journal"><string-name><surname>Song</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Tan</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Miao</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>M</given-names>
</string-name>
, <string-name><surname>Zhang</surname>
<given-names>Q</given-names>
</string-name>
. <article-title>Crosstalk of autophagy and apoptosis: involvement of the dual role of autophagy under ER stress</article-title>
. <source><italic toggle="yes">J Cell Physiol</italic>
</source>
. <year>2017</year>
. doi:<pub-id pub-id-type="doi">10.1002/jcp.25785</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0016"><label>16.</label>
<mixed-citation publication-type="journal"><string-name><surname>Bursch</surname>
<given-names>W</given-names>
</string-name>
. <article-title>The autophagosomal-lysosomal compartment in programmed cell death</article-title>
. <source><italic toggle="yes">Cell Death Differ</italic>
</source>
. <year>2001</year>
;<volume>8</volume>
(<issue>6</issue>
):<fpage>569</fpage>
–<lpage>581</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/sj.cdd.4400852</pub-id>
<pub-id pub-id-type="pmid">11536007</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0017"><label>17.</label>
<mixed-citation publication-type="journal"><string-name><surname>Lockshin</surname>
<given-names>RA</given-names>
</string-name>
, <string-name><surname>Zakeri</surname>
<given-names>Z</given-names>
</string-name>
. <article-title>Programmed cell death and apoptosis: origins of the theory</article-title>
. <source><italic toggle="yes">Nat Rev Mol Cell Biol</italic>
</source>
. <year>2001</year>
;<volume>2</volume>
(<issue>7</issue>
):<fpage>545</fpage>
–<lpage>550</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/35080097</pub-id>
<pub-id pub-id-type="pmid">11433369</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0018"><label>18.</label>
<mixed-citation publication-type="journal"><string-name><surname>Edinger</surname>
<given-names>AL</given-names>
</string-name>
, <string-name><surname>Thompson</surname>
<given-names>CB</given-names>
</string-name>
. <article-title>Death by design: apoptosis, necrosis and autophagy</article-title>
. <source><italic toggle="yes">Curr Opin Cell Biol</italic>
</source>
. <year>2004</year>
;<volume>16</volume>
(<issue>6</issue>
):<fpage>663</fpage>
–<lpage>669</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.ceb.2004.09.011</pub-id>
<pub-id pub-id-type="pmid">15530778</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0019"><label>19.</label>
<mixed-citation publication-type="journal"><string-name><surname>de Bruin</surname>
<given-names>EC</given-names>
</string-name>
, <string-name><surname>Medema</surname>
<given-names>JP</given-names>
</string-name>
. <article-title>Apoptosis and non-apoptotic deaths in cancer development and treatment response</article-title>
. <source><italic toggle="yes">Cancer Treat Rev</italic>
</source>
. <year>2008</year>
;<volume>34</volume>
(<issue>8</issue>
):<fpage>737</fpage>
–<lpage>749</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.ctrv.2008.07.001</pub-id>
<pub-id pub-id-type="pmid">18722718</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0020"><label>20.</label>
<mixed-citation publication-type="journal"><string-name><surname>Bialik</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Zalckvar</surname>
<given-names>E</given-names>
</string-name>
, <string-name><surname>Ber</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Rubinstein</surname>
<given-names>AD</given-names>
</string-name>
, <string-name><surname>Kimchi</surname>
<given-names>A</given-names>
</string-name>
. <article-title>Systems biology analysis of programmed cell death</article-title>
. <source><italic toggle="yes">Trends Biochem Sci</italic>
</source>
. <year>2010</year>
;<volume>35</volume>
(<issue>10</issue>
):<fpage>556</fpage>
–<lpage>564</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.tibs.2010.04.008</pub-id>
<pub-id pub-id-type="pmid">20537543</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0021"><label>21.</label>
<mixed-citation publication-type="journal"><string-name><surname>Eisenberg-Lerner</surname>
<given-names>A</given-names>
</string-name>
, <string-name><surname>Bialik</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Simon</surname>
<given-names>HU</given-names>
</string-name>
, <string-name><surname>Kimchi</surname>
<given-names>A</given-names>
</string-name>
. <article-title>Life and death partners: apoptosis, autophagy and the cross-talk between them</article-title>
. <source><italic toggle="yes">Cell Death Differ</italic>
</source>
. <year>2009</year>
;<volume>16</volume>
(<issue>7</issue>
):<fpage>966</fpage>
–<lpage>975</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/cdd.2009.33</pub-id>
<pub-id pub-id-type="pmid">19325568</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0022"><label>22.</label>
<mixed-citation publication-type="journal"><string-name><surname>Sheng</surname>
<given-names>H</given-names>
</string-name>
, <string-name><surname>Sun</surname>
<given-names>H</given-names>
</string-name>
. <article-title>Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases</article-title>
. <source><italic toggle="yes">Natural Product Reports</italic>
</source>
. <year>2011</year>
;<volume>28</volume>
(<issue>3</issue>
):<fpage>543</fpage>
–<lpage>593</lpage>
. doi:<pub-id pub-id-type="doi">10.1039/c0np00059k</pub-id>
<pub-id pub-id-type="pmid">21290067</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0023"><label>23.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liby</surname>
<given-names>KT</given-names>
</string-name>
, <string-name><surname>Sporn</surname>
<given-names>MB</given-names>
</string-name>
. <article-title>Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease</article-title>
. <source><italic toggle="yes">Pharmacol Rev</italic>
</source>
. <year>2012</year>
;<volume>64</volume>
(<issue>4</issue>
):<fpage>972</fpage>
–<lpage>1003</lpage>
. doi:<pub-id pub-id-type="doi">10.1124/pr.111.004846</pub-id>
<pub-id pub-id-type="pmid">22966038</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0024"><label>24.</label>
<mixed-citation publication-type="journal"><string-name><surname>Pollier</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Goossens</surname>
<given-names>A</given-names>
</string-name>
. <article-title>Oleanolic acid</article-title>
. <source><italic toggle="yes">Phytochemistry</italic>
</source>
. <year>2012</year>
;<volume>77</volume>
:<fpage>10</fpage>
–<lpage>15</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.phytochem.2011.12.022</pub-id>
<pub-id pub-id-type="pmid">22377690</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0025"><label>25.</label>
<mixed-citation publication-type="journal"><string-name><surname>Topcu</surname>
<given-names>G</given-names>
</string-name>
, <string-name><surname>Tan</surname>
<given-names>N</given-names>
</string-name>
, <string-name><surname>Kokdil</surname>
<given-names>G</given-names>
</string-name>
, <string-name><surname>Ulubelen</surname>
<given-names>A</given-names>
</string-name>
. <article-title>Terpenoids from Salvia glutinosa</article-title>
. <source><italic toggle="yes">Phytochemistry</italic>
</source>
. <year>1997</year>
;<volume>45</volume>
(<issue>6</issue>
):<fpage>1293</fpage>
–<lpage>1294</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/s0031-9422(97)00042-3</pub-id>
<pub-id pub-id-type="pmid">9272969</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0026"><label>26.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Zheng</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Zhong</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Wu</surname>
<given-names>N</given-names>
</string-name>
, <string-name><surname>Liu</surname>
<given-names>G</given-names>
</string-name>
, <string-name><surname>Lin</surname>
<given-names>X</given-names>
</string-name>
. <article-title>Oleanolic acid induces protective autophagy in cancer cells through the JNK and mTOR pathways</article-title>
. <source><italic toggle="yes">Oncol Rep</italic>
</source>
. <year>2014</year>
;<volume>32</volume>
(<issue>2</issue>
):<fpage>567</fpage>
–<lpage>572</lpage>
. doi:<pub-id pub-id-type="doi">10.3892/or.2014.3239</pub-id>
<pub-id pub-id-type="pmid">24912497</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0027"><label>27.</label>
<mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Wang</surname>
<given-names>K</given-names>
</string-name>
, <string-name><surname>Lei</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>Q</given-names>
</string-name>
, <string-name><surname>Nice</surname>
<given-names>EC</given-names>
</string-name>
, <string-name><surname>Huang</surname>
<given-names>C</given-names>
</string-name>
. <article-title>Redox signaling: potential arbitrator of autophagy and apoptosis in therapeutic response</article-title>
. <source><italic toggle="yes">Free Radic Biol Med</italic>
</source>
. <year>2015</year>
;<volume>89</volume>
:<fpage>452</fpage>
–<lpage>465</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.08.030</pub-id>
<pub-id pub-id-type="pmid">26454086</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0028"><label>28.</label>
<mixed-citation publication-type="journal"><string-name><surname>Poillet-Perez</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Despouy</surname>
<given-names>G</given-names>
</string-name>
, <string-name><surname>Delage-Mourroux</surname>
<given-names>R</given-names>
</string-name>
, <string-name><surname>Boyer-Guittaut</surname>
<given-names>M</given-names>
</string-name>
. <article-title>Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy</article-title>
. <source><italic toggle="yes">Redox Biol</italic>
</source>
. <year>2015</year>
;<volume>4</volume>
:<fpage>184</fpage>
–<lpage>192</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.redox.2014.12.003</pub-id>
<pub-id pub-id-type="pmid">25590798</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0029"><label>29.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kaminskyy</surname>
<given-names>VO</given-names>
</string-name>
, <string-name><surname>Zhivotovsky</surname>
<given-names>B</given-names>
</string-name>
. <article-title>Free radicals in cross talk between autophagy and apoptosis</article-title>
. <source><italic toggle="yes">Antioxid Redox Signal</italic>
</source>
. <year>2014</year>
;<volume>21</volume>
(<issue>1</issue>
):<fpage>86</fpage>
–<lpage>102</lpage>
. doi:<pub-id pub-id-type="doi">10.1089/ars.2013.5746</pub-id>
<pub-id pub-id-type="pmid">24359220</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0030"><label>30.</label>
<mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>
<given-names>YY</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Jiang</surname>
<given-names>WQ</given-names>
</string-name>
, <string-name><surname>Zhou</surname>
<given-names>LF</given-names>
</string-name>
. <article-title>MAPK/JNK signalling: a potential autophagy regulation pathway</article-title>
. <source><italic toggle="yes">Biosci Rep</italic>
</source>
. <year>2015</year>
;<volume>35</volume>
:<fpage>3</fpage>
. doi:<pub-id pub-id-type="doi">10.1042/BSR20150111</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0031"><label>31.</label>
<mixed-citation publication-type="journal"><string-name><surname>He</surname>
<given-names>W</given-names>
</string-name>
, <string-name><surname>Wang</surname>
<given-names>Q</given-names>
</string-name>
, <string-name><surname>Srinivasan</surname>
<given-names>B</given-names>
</string-name>
, et al. <article-title>A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy</article-title>
. <source><italic toggle="yes">Oncogene</italic>
</source>
. <year>2014</year>
;<volume>33</volume>
(<issue>23</issue>
):<fpage>3004</fpage>
–<lpage>3013</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/onc.2013.256</pub-id>
<pub-id pub-id-type="pmid">23831571</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0032"><label>32.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>YC</given-names>
</string-name>
, <string-name><surname>Guan</surname>
<given-names>KL</given-names>
</string-name>
. <article-title>mTOR: a pharmacologic target for autophagy regulation</article-title>
. <source><italic toggle="yes">J Clin Invest</italic>
</source>
. <year>2015</year>
;<volume>125</volume>
(<issue>1</issue>
):<fpage>25</fpage>
–<lpage>32</lpage>
. doi:<pub-id pub-id-type="doi">10.1172/JCI73939</pub-id>
<pub-id pub-id-type="pmid">25654547</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0033"><label>33.</label>
<mixed-citation publication-type="journal"><string-name><surname>Simmons</surname>
<given-names>CP</given-names>
</string-name>
, <string-name><surname>Koinis</surname>
<given-names>F</given-names>
</string-name>
, <string-name><surname>Fallon</surname>
<given-names>MT</given-names>
</string-name>
, et al. <article-title>Prognosis in advanced lung cancer–A prospective study examining key clinicopathological factors</article-title>
. <source><italic toggle="yes">Lung Cancer</italic>
</source>
. <year>2015</year>
;<volume>88</volume>
(<issue>3</issue>
):<fpage>304</fpage>
–<lpage>309</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.lungcan.2015.03.020</pub-id>
<pub-id pub-id-type="pmid">25870155</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0034"><label>34.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yoshikawa</surname>
<given-names>M</given-names>
</string-name>
, <string-name><surname>Matsuda</surname>
<given-names>H</given-names>
</string-name>
. <article-title>Antidiabetogenic activity of oleanolic acid glycosides from medicinal foodstuffs</article-title>
. <source><italic toggle="yes">Biofactors</italic>
</source>
. <year>2000</year>
;<volume>13</volume>
(<issue>1–4</issue>
):<fpage>231</fpage>
–<lpage>237</lpage>
.<pub-id pub-id-type="pmid">11237187</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0035"><label>35.</label>
<mixed-citation publication-type="journal"><string-name><surname>Watjen</surname>
<given-names>W</given-names>
</string-name>
, <string-name><surname>Michels</surname>
<given-names>G</given-names>
</string-name>
, <string-name><surname>Steffan</surname>
<given-names>B</given-names>
</string-name>
, et al. <article-title>Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis</article-title>
. <source><italic toggle="yes">J Nutr</italic>
</source>
. <year>2005</year>
;<volume>135</volume>
(<issue>3</issue>
):<fpage>525</fpage>
–<lpage>531</lpage>
. doi:<pub-id pub-id-type="doi">10.1093/jn/135.3.525</pub-id>
<pub-id pub-id-type="pmid">15735088</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0036"><label>36.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yu</surname>
<given-names>C</given-names>
</string-name>
, <string-name><surname>Li</surname>
<given-names>WB</given-names>
</string-name>
, <string-name><surname>Liu</surname>
<given-names>JB</given-names>
</string-name>
, <string-name><surname>Lu</surname>
<given-names>JW</given-names>
</string-name>
, <string-name><surname>Feng</surname>
<given-names>JF</given-names>
</string-name>
. <article-title>Autophagy: novel applications of nonsteroidal anti-inflammatory drugs for primary cancer</article-title>
. <source><italic toggle="yes">Cancer Med</italic>
</source>
. <year>2018</year>
;<volume>7</volume>
(<issue>2</issue>
):<fpage>471</fpage>
–<lpage>484</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/cam4.1287</pub-id>
<pub-id pub-id-type="pmid">29282893</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0037"><label>37.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kohli</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Roth</surname>
<given-names>KA</given-names>
</string-name>
. <article-title>Autophagy: cerebral home cooking</article-title>
. <source><italic toggle="yes">Am J Pathol</italic>
</source>
. <year>2010</year>
;<volume>176</volume>
(<issue>3</issue>
):<fpage>1065</fpage>
–<lpage>1071</lpage>
. doi:<pub-id pub-id-type="doi">10.2353/ajpath.2010.090850</pub-id>
<pub-id pub-id-type="pmid">20150434</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0038"><label>38.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yousefi</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Simon</surname>
<given-names>HU</given-names>
</string-name>
. <article-title>Apoptosis regulation by autophagy gene 5</article-title>
. <source><italic toggle="yes">Crit Rev Oncol Hematol</italic>
</source>
. <year>2007</year>
;<volume>63</volume>
(<issue>3</issue>
):<fpage>241</fpage>
–<lpage>244</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.critrevonc.2007.06.005</pub-id>
<pub-id pub-id-type="pmid">17644402</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0039"><label>39.</label>
<mixed-citation publication-type="journal"><string-name><surname>Wirawan</surname>
<given-names>E</given-names>
</string-name>
, <string-name><surname>Lippens</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Vanden Berghe</surname>
<given-names>T</given-names>
</string-name>
, et al. <article-title>Beclin1: a role in membrane dynamics and beyond</article-title>
. <source><italic toggle="yes">Autophagy</italic>
</source>
. <year>2012</year>
;<volume>8</volume>
(<issue>1</issue>
):<fpage>6</fpage>
–<lpage>17</lpage>
. doi:<pub-id pub-id-type="doi">10.4161/auto.8.1.16645</pub-id>
<pub-id pub-id-type="pmid">22170155</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0040"><label>40.</label>
<mixed-citation publication-type="journal"><string-name><surname>Gomez-Puerto</surname>
<given-names>MC</given-names>
</string-name>
, <string-name><surname>Folkerts</surname>
<given-names>H</given-names>
</string-name>
, <string-name><surname>Wierenga</surname>
<given-names>AT</given-names>
</string-name>
, et al. <article-title>Autophagy proteins ATG5 and ATG7 are essential for the maintenance of human CD34(+) hematopoietic stem-progenitor cells</article-title>
. <source><italic toggle="yes">Stem Cells</italic>
</source>
. <year>2016</year>
;<volume>34</volume>
(<issue>6</issue>
):<fpage>1651</fpage>
–<lpage>1663</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/stem.2347</pub-id>
<pub-id pub-id-type="pmid">26930546</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0041"><label>41.</label>
<mixed-citation publication-type="journal"><string-name><surname>Abedin</surname>
<given-names>MJ</given-names>
</string-name>
, <string-name><surname>Wang</surname>
<given-names>D</given-names>
</string-name>
, <string-name><surname>McDonnell</surname>
<given-names>MA</given-names>
</string-name>
, <string-name><surname>Lehmann</surname>
<given-names>U</given-names>
</string-name>
, <string-name><surname>Kelekar</surname>
<given-names>A</given-names>
</string-name>
. <article-title>Autophagy delays apoptotic death in breast cancer cells following DNA damage</article-title>
. <source><italic toggle="yes">Cell Death Differ</italic>
</source>
. <year>2007</year>
;<volume>14</volume>
(<issue>3</issue>
):<fpage>500</fpage>
–<lpage>510</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/sj.cdd.4402039</pub-id>
<pub-id pub-id-type="pmid">16990848</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0042"><label>42.</label>
<mixed-citation publication-type="journal"><string-name><surname>Claerhout</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Verschooten</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Van Kelst</surname>
<given-names>S</given-names>
</string-name>
, et al. <article-title>Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma</article-title>
. <source><italic toggle="yes">Int J Cancer</italic>
</source>
. <year>2010</year>
;<volume>127</volume>
(<issue>12</issue>
):<fpage>2790</fpage>
–<lpage>2803</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/ijc.25300</pub-id>
<pub-id pub-id-type="pmid">21351258</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0043"><label>43.</label>
<mixed-citation publication-type="journal"><string-name><surname>Ren</surname>
<given-names>JH</given-names>
</string-name>
, <string-name><surname>He</surname>
<given-names>WS</given-names>
</string-name>
, <string-name><surname>Nong</surname>
<given-names>L</given-names>
</string-name>
, et al. <article-title>Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy</article-title>
. <source><italic toggle="yes">Cancer Biother Radiopharm</italic>
</source>
. <year>2010</year>
;<volume>25</volume>
(<issue>1</issue>
):<fpage>75</fpage>
–<lpage>80</lpage>
. doi:<pub-id pub-id-type="doi">10.1089/cbr.2009.0701</pub-id>
<pub-id pub-id-type="pmid">20187799</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0044"><label>44.</label>
<mixed-citation publication-type="journal"><string-name><surname>O’Donovan</surname>
<given-names>TR</given-names>
</string-name>
, <string-name><surname>O’Sullivan</surname>
<given-names>GC</given-names>
</string-name>
, <string-name><surname>McKenna</surname>
<given-names>SL</given-names>
</string-name>
. <article-title>Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics</article-title>
. <source><italic toggle="yes">Autophagy</italic>
</source>
. <year>2011</year>
;<volume>7</volume>
(<issue>5</issue>
):<fpage>509</fpage>
–<lpage>524</lpage>
. doi:<pub-id pub-id-type="doi">10.4161/auto.7.6.15066</pub-id>
<pub-id pub-id-type="pmid">21325880</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0045"><label>45.</label>
<mixed-citation publication-type="journal"><string-name><surname>Aoki</surname>
<given-names>H</given-names>
</string-name>
, <string-name><surname>Takada</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Kondo</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Sawaya</surname>
<given-names>R</given-names>
</string-name>
, <string-name><surname>Aggarwal</surname>
<given-names>BB</given-names>
</string-name>
, <string-name><surname>Kondo</surname>
<given-names>Y</given-names>
</string-name>
. <article-title>Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways</article-title>
. <source><italic toggle="yes">Mol Pharmacol</italic>
</source>
. <year>2007</year>
;<volume>72</volume>
(<issue>1</issue>
):<fpage>29</fpage>
–<lpage>39</lpage>
. doi:<pub-id pub-id-type="doi">10.1124/mol.106.033167</pub-id>
<pub-id pub-id-type="pmid">17395690</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0046"><label>46.</label>
<mixed-citation publication-type="journal"><string-name><surname>Song</surname>
<given-names>Y</given-names>
</string-name>
, <string-name><surname>Kong</surname>
<given-names>L</given-names>
</string-name>
, <string-name><surname>Sun</surname>
<given-names>B</given-names>
</string-name>
, et al. <article-title>Induction of autophagy by an oleanolic acid derivative, SZC017, promotes ROS-dependent apoptosis through Akt and JAK2/STAT3 signaling pathway in human lung cancer cells</article-title>
. <source><italic toggle="yes">Cell Biol Int</italic>
</source>
. <year>2017</year>
;<volume>41</volume>
(<issue>12</issue>
):<fpage>1367</fpage>
–<lpage>1378</lpage>
. doi:<pub-id pub-id-type="doi">10.1002/cbin.10868</pub-id>
<pub-id pub-id-type="pmid">28880428</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0047"><label>47.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kyriakis</surname>
<given-names>JM</given-names>
</string-name>
, <string-name><surname>Banerjee</surname>
<given-names>P</given-names>
</string-name>
, <string-name><surname>Nikolakaki</surname>
<given-names>E</given-names>
</string-name>
, et al. <article-title>The stress-activated protein kinase subfamily of c-Jun kinases</article-title>
. <source><italic toggle="yes">Nature</italic>
</source>
. <year>1994</year>
;<volume>369</volume>
(<issue>6476</issue>
):<fpage>156</fpage>
–<lpage>160</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/369156a0</pub-id>
<pub-id pub-id-type="pmid">8177321</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0048"><label>48.</label>
<mixed-citation publication-type="journal"><string-name><surname>Xavier</surname>
<given-names>CP</given-names>
</string-name>
, <string-name><surname>Lima</surname>
<given-names>CF</given-names>
</string-name>
, <string-name><surname>Pedro</surname>
<given-names>DF</given-names>
</string-name>
, <string-name><surname>Wilson</surname>
<given-names>JM</given-names>
</string-name>
, <string-name><surname>Kristiansen</surname>
<given-names>K</given-names>
</string-name>
, <string-name><surname>Pereira-Wilson</surname>
<given-names>C</given-names>
</string-name>
. <article-title>Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells</article-title>
. <source><italic toggle="yes">J Nutr Biochem</italic>
</source>
. <year>2013</year>
;<volume>24</volume>
(<issue>4</issue>
):<fpage>706</fpage>
–<lpage>712</lpage>
. doi:<pub-id pub-id-type="doi">10.1016/j.jnutbio.2012.04.004</pub-id>
<pub-id pub-id-type="pmid">22841540</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0049"><label>49.</label>
<mixed-citation publication-type="journal"><string-name><surname>Nakano</surname>
<given-names>H</given-names>
</string-name>
, <string-name><surname>Nakajima</surname>
<given-names>A</given-names>
</string-name>
, <string-name><surname>Sakon-Komazawa</surname>
<given-names>S</given-names>
</string-name>
, <string-name><surname>Piao</surname>
<given-names>JH</given-names>
</string-name>
, <string-name><surname>Xue</surname>
<given-names>X</given-names>
</string-name>
, <string-name><surname>Okumura</surname>
<given-names>K</given-names>
</string-name>
. <article-title>Reactive oxygen species mediate crosstalk between NF-kappaB and JNK</article-title>
. <source><italic toggle="yes">Cell Death Differ</italic>
</source>
. <year>2006</year>
;<volume>13</volume>
(<issue>5</issue>
):<fpage>730</fpage>
–<lpage>737</lpage>
. doi:<pub-id pub-id-type="doi">10.1038/sj.cdd.4401830</pub-id>
<pub-id pub-id-type="pmid">16341124</pub-id>
</mixed-citation>
</ref>
<ref id="CIT0050"><label>50.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>J</given-names>
</string-name>
, <string-name><surname>Wu</surname>
<given-names>N</given-names>
</string-name>
, <string-name><surname>Ma</surname>
<given-names>LN</given-names>
</string-name>
, et al. <article-title>p38 MAPK signaling mediates mitochondrial apoptosis in cancer cells induced by oleanolic acid</article-title>
. <source><italic toggle="yes">Asian Pac J Cancer Prev</italic>
</source>
. <year>2014</year>
;<volume>15</volume>
(<issue>11</issue>
):<fpage>4519</fpage>
–<lpage>4525</lpage>
. doi:<pub-id pub-id-type="doi">10.7314/apjcp.2014.15.11.4519</pub-id>
<pub-id pub-id-type="pmid">24969879</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Pmc/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000739 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000739 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:6815788
   |texte=   Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:31695422" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021

	Serveur d'exploration Chloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Chloroquine

Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation

Methyloleanolate Induces Apoptotic And Autophagic Cell Death Via Reactive Oxygen Species Generation And c-Jun N-terminal Kinase Phosphorylation

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki